25 April 2017
The Canadian Centre for Ethics in Sport (CCES) announced today that Vincent Figliomeni, a U SPORTS hockey player from Ryerson University, received a two-month sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on February 2, 2017, revealed the presence of cannabis.
The presence of cannabis, classified as a “specified substance” on the 2017 Prohibited List, is considered an adverse analytical finding when the urinary concentration exceeds 150 ng/mL. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” can seek to have the sanction reduced to a reprimand. Based on CCES’ assessment of the athlete's degree of fault, the CCES proposed a two-month period of ineligibility.
In response to the CCES’ notification of the adverse analytical finding, Mr. Figliomeni admitted the violation in a timely fashion (in accordance with CADP Rule 10.11.2), waived his right to a hearing and accepted a sanction of two months ineligibility from sport (which terminated on April 10, 2017). The athlete, who resides in Toronto, Ontario, was ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates, during the sanction period.
In compliance with rule 7.10 of the CADP, a copy of the CCES’ file summary can be found at www.cces.ca/canadian-sport-sanction-registry.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.